Neurexin-1
| GO Term | Evidence Code | Reference |
|---|---|---|
| vesicle docking involved in exocytosis |
|
|
| chemical synaptic transmission | ||
| chemical synaptic transmission | ||
| neurotransmitter secretion | ||
| neurotransmitter secretion |
| GO Term | Evidence Code | Reference |
|---|---|---|
| nucleolus |
|
|
| endoplasmic reticulum | ||
| endoplasmic reticulum | ||
| plasma membrane | ||
| plasma membrane |
| GO Term | Evidence Code | Reference |
|---|---|---|
| type 1 fibroblast growth factor receptor binding | ||
| calcium channel regulator activity | ||
| calcium channel regulator activity | ||
| calcium ion binding | ||
| acetylcholine receptor binding |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 125 |
|
|
||
| 190 |
|
|
||
| 813 |
|
|
||
| 1246 |
|
|
||
| 1408 |
|
|
| Pathway Name | Organism |
|---|---|
| Neurexins and neuroligins | Rattus norvegicus |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0060041 | autism spectrum disorder |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026